Results per Page:
Oncology Insights with Dr. Petros Grivas - Episode 13
Dr. Jonathan Wright discusses risk factors, early detection and advances in bladder cancer care
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 01, 2026
Dr. Hans-Peter Kiem receives ASGCT mentorship award
Fred Hutch gene therapy expert views mentorship as a lifelong commitment
Bringing gene therapy to esophageal cancer, one sip at a time
From the Stephan Lab, Translational Science and Therapeutics Division
How targeted radiation reshapes the bone marrow
From the Termini Lab, Translational Science and Therapeutics Division
Umbilical cord blood transplant with pooled stem cell product shows 96% survival and no graft-versus-host-disease in leukemia patients
A phase 2 study published in the Journal of Clinical Oncology shows that a stem cell product called dilanubicel safely enabled umbilical cord blood transplants in 28 patients
Oncology Insights with Dr. Petros Grivas - Episode 12
Dr. Stanley Riddell traces his journey from bone marrow transplantation to CAR T-cell therapies in a new podcast episode
Fred Hutch researchers test privacy-first AI platform for cancer research
After a year of building the infrastructure for its federated learning platform, the Cancer AI Alliance (CAIA) is road-testing eight projects using de-identified clinical data from four comprehensive cancer centers
Naturally killing thymus regeneration
From the Dudakov Lab, Translational Science and Therapeutics Division
Made to last: engineering durable CAR-T cells
From the Peterson and Kiem Labs, Translational Science and Therapeutics Division
Conducting RNA reconnaissance
Fred Hutch researchers invent a CRISPR screening method to understand RNA-binding proteins often mutated in cancer and other diseases
‘Manufacturing scientist’ believes in the machinery that powers Fred Hutch’s cell therapies
Dr. Folashade Otegbeye is the recipient of the Fleischauer Family Endowed Chair in Cell and Gene Therapy Translation
Patients’ own autoantibodies may hold key to boosting cancer immunotherapy response
A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments
Age-dependent genetic alterations in AML patients
From the Meshinchi Lab, Translational Science & Therapeutics Division
Premature immune aging occurs in children with leukemia
From Drs. Kavita Dhodapkar and Madhav Dhodapkar, Translational Science & Therapeutics Division
Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award
National award honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science